Counsell N
ORCID: 0000-0002-0688-9192
· 1 paper in corpus
nonrandomized-trial
2025
IMPORTANCE: Advanced clear cell gynecological cancers (CCGCs) have a poor prognosis, with response rates to second-line chemotherapy less than 8%. Preliminary clinical activity with programmed cell death 1 protein (PD-1) inhibitors reported…